Paratek Pharmaceuticals' Total Revenue For Q2 FY23 Was $40M Compared To $29.6M For The Same Period In The Prior Year, Beating The Consensus Of $33.85M
Portfolio Pulse from Benzinga Newsdesk
Paratek Pharmaceuticals' Q2 FY23 total revenue was $40M, surpassing the consensus of $33.85M and the prior year's $29.6M.
August 04, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Paratek Pharmaceuticals reported a Q2 FY23 total revenue of $40M, beating the consensus estimate of $33.85M and the prior year's $29.6M.
Paratek Pharmaceuticals' Q2 FY23 revenue exceeded both the consensus estimate and the revenue for the same period in the prior year. This positive financial performance could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100